Cargando…

Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients

Certain host genetic variants, especially in the human leucocyte antigen (HLA) region, are associated with different progression of HIV-1-induced diseases and AIDS. Long term non progressors (LTNP) represent only the 2% of infected patients but are especially relevant because of their efficient HIV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramírez de Arellano, Eva, Díez-Fuertes, Francisco, Aguilar, Francisco, de la Torre Tarazona, Humberto Erick, Sánchez-Lara, Susana, Lao, Yolanda, Vicario, José Luis, García, Felipe, González-Garcia, Juan, Pulido, Federico, Gutierrez-Rodero, Félix, Moreno, Santiago, Iribarren, Jose Antonio, Viciana, Pompeyo, Vilches, Carlos, Ramos, Manuel, Capa, Laura, Alcamí, José, Del Val, Margarita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687284/ https://www.ncbi.nlm.nih.gov/pubmed/31393887 http://dx.doi.org/10.1371/journal.pone.0220459

Ejemplares similares

Elite controllers long-term non progressors present improved survival and slower disease progression
por: Capa, Laura, et al.
Publicado: (2022)

Transcriptome Sequencing of Peripheral Blood Mononuclear Cells from Elite Controller-Long Term Non Progressors
por: Díez-Fuertes, Francisco, et al.
Publicado: (2019)

Insight in miRNome of Long-Term Non-Progressors and Elite Controllers Exposes Potential RNAi Role in Restraining HIV-1 Infection
por: Ayala-Suárez, Rubén, et al.
Publicado: (2020)

Omic Technologies in HIV: Searching Transcriptional Signatures Involved in Long-Term Non-Progressor and HIV Controller Phenotypes
por: De La Torre-Tarazona, Erick, et al.
Publicado: (2022)

Octogenarians with chronic kidney disease in the nephrology clinic: Progressors vs. non-progressors
por: Frías, Aida, et al.
Publicado: (2023)

Increased Prevalence of Unstable HLA-C Variants in HIV-1 Rapid-Progressor Patients
por: Stefani, Chiara, et al.
Publicado: (2022)

Distinct antibody profiles in HLA-B(∗)57(+), HLA-B(∗)57(−) HIV controllers and chronic progressors
por: Klingler, Jéromine, et al.
Publicado: (2022)

Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors
por: González, Nuria, et al.
Publicado: (2018)

TP53/p53 alterations and Aurora A expression in progressor and non-progressor colectomies from patients with longstanding ulcerative colitis
por: FRIIS-OTTESSEN, MARIANN, et al.
Publicado: (2015)

Are Long-Term Non-Progressors Very Slow Progressors? Insights from the Chelsea and Westminster HIV Cohort, 1988–2010
por: Mandalia, Sundhiya, et al.
Publicado: (2012)

Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase
por: Eckstrand, C. D., et al.
Publicado: (2016)

Array Comparative Genomic Hybridization in Ulcerative Colitis Neoplasia: Single Non-Dysplastic Biopsies Distinguish Progressors from Non-Progressors
por: Bronner, Mary P., et al.
Publicado: (2010)

Factors associated with conversion of long-term non-progressors to progressors: A prospective study of HIV perinatally infected paediatric survivors
por: Radhakrishna, Muttineni, et al.
Publicado: (2013)

Serological identification of fast progressors of structural damage with rheumatoid arthritis
por: Siebuhr, Anne Sofie, et al.
Publicado: (2013)

HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India
por: Swathirajan, Chinnambedu Ravichandran, et al.
Publicado: (2018)

Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors
por: Geskus, Ronald B., et al.
Publicado: (2016)

HLA and non-HLA genes in Behçet’s disease: a multicentric study in the Spanish population
por: Montes-Cano, Marco Antonio, et al.
Publicado: (2012)

Impact of Transcriptome and Gut Microbiome on the Response of HIV-1 Infected Individuals to a Dendritic Cell-Based HIV Therapeutic Vaccine
por: Pastor-Ibáñez, Roque, et al.
Publicado: (2021)

Evaluation of Rapid Progressors in HIV Infection as an Extreme Phenotype
por: Olson, Ashley D., et al.
Publicado: (2014)

Long term non-progressor (LTNP) HIV infection
por: Kumar, Praveen
Publicado: (2013)

Percentage of progressors in imaging: can we ignore regressors?
por: Sepriano, Alexandre, et al.
Publicado: (2019)

Relato histórico de la infectología española
por: María Aguado García, José, et al.
Publicado: (2008)

Clinical Outcome of HIV-Infected Patients with Sustained Virologic Response to Antiretroviral Therapy: Long-Term Follow-Up of a Multicenter Cohort
por: Gutierrez, Félix, et al.
Publicado: (2006)

Differential MicroRNA Expression Profile between Stimulated PBMCs from HIV-1 Infected Elite Controllers and Viremic Progressors
por: Egaña-Gorroño, Lander, et al.
Publicado: (2014)

Tanatología medicoforense : la fragilidad de la existencia humana /
por: García Arellano, José Francisco
Publicado: (2015)

Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers
por: Dam, Erik B, et al.
Publicado: (2009)

Hydroxytyrosol: a new class of microbicide displaying broad anti-HIV-1 activity
por: Bedoya, Luis M., et al.
Publicado: (2016)

Baseline clinical characteristics of predicted structural and pain progressors in the IMI-APPROACH knee OA cohort
por: van Helvoort, Eefje Martine, et al.
Publicado: (2021)

Rapid and Slow Progressors Show Increased IL-6 and IL-10 Levels in the Pre-AIDS Stage of HIV Infection
por: de Medeiros, Rúbia M., et al.
Publicado: (2016)

The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study
por: Meijerink, Hinta, et al.
Publicado: (2014)

Dyslipidemia and Cardiovascular Disease Risk Factor Management in HIV-1-Infected Subjects Treated with HAART in the Spanish VACH Cohort
por: Domingo, Pere, et al.
Publicado: (2008)

Non-polarized cytokine profile of a long-term non-progressor HIV infected patient
por: Pina, Ana Flávia, et al.
Publicado: (2018)

Preferential targeting of co-evolving Gag residues in long-term non progressors
por: Sunshine, J, et al.
Publicado: (2012)

Unexpected Response to Nivolumab in a “Fast Progressor” Head and Neck Cancer Patient
por: Napolitano, Martina, et al.
Publicado: (2019)

HLA and non-HLA genes in Behçet’s disease: a multicentric study in the Spanish population
por: Montes-Cano, Marco Antonio, et al.
Publicado: (2013)

Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain
por: Diaz, Asuncion, et al.
Publicado: (2010)

Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study
por: Ascaso-del-Rio, Ana, et al.
Publicado: (2022)

Enhanced β-carotene and Biomass Production by Induced Mixotrophy in Dunaliella salina across a Combined Strategy of Glycerol, Salinity, and Light
por: Capa-Robles, Willian, et al.
Publicado: (2021)

KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors
por: Jiang, Yongjun, et al.
Publicado: (2013)

Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort
por: Estrada, Vicente, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_f5n4hr2aj4rnm2hr21is6582pr